NeoRx, Schwarz Pharma deal

The companies will develop NERX's Biostent to treat restenosis (reclosing of arteries) following balloon

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE